Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Senate panel questions Novo Nordisk CEO over decision to discontinue this popular insulin
Novo Nordisk CEO explains decision to discontinue the long-acting insulin Levemir. He blamed pharmacy managers and health insurers.
'Stop ripping us off,' says Sen. Sanders, but Novo CEO blames PBMs for high Wegovy prices
Novo Nordisk has a price fix solution for uninsured patients with diabetes, but not for HSA holders or people with normal blood sugar.
Novo Nordisk CEO To Face Senate Scrutiny Over High Ozempic And Wegovy Prices, Hearing Scheduled On Tuesday
Novo Nordisk CEO Lars Fruergaard Jørgensen faces a Senate hearing led by Bernie Sanders over the high cost of Ozempic and Wegovy, as U.S. lawmakers push for drug price reductions.
Senators press Novo Nordisk CEO on why Ozempic and Wegovy cost less abroad
Weight-loss drugs sell in Europe for a fraction of what they cost in the United States, a pattern that is typical for brand-name prescriptions.
Why does Ozempic cost so much? Senators grilled Novo Nordisk CEO for answers.
Novo Nordisk CEO grilled over company's pricing for the diabetes drug Ozempic and the weight-loss drug Wegovy.
Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices
Sen. Bernie Sanders argues that Novo Nordisk charges Americans substantially higher prices for its drugs than it does for patients in other countries.
Sanders leads HELP Committee hearing with Novo Nordisk CEO on Ozempic and Wegovy prices
Chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP), today led the committee in a hearing to examine why Novo Nordisk charges the American people the highest prices in the world for its lifesaving drugs,
Novo Nordisk CEO criticized by lawmakers over high Ozempic price
Novo Nordisk CEO Lars Fruergaard Jørgensen, however, said that lowering the prices could result in unintended consequences like the drug being dropped completely from insurance companies.
Opinion
Novo Nordisk CEO blames PBMs, insurers for Ozempic price tag
Senate HELP Chairman Bernie Sanders launches another salvo in drug pricing war, this one aimed at popular weight loss drugs.
Novo Nordisk CEO Grilled by Congress Over Price of Ozempic
During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions over the company's high prices for its blockbuster drugs Ozempic and Wegovy.
Ozempic maker's CEO grilled over price of weight loss drugs
The CEO of the company that makes Ozempic faced a Bernie Sanders-led Senate hearing on Tuesday.
WBIW
2h
Braun to Novo Nordisk CEO: “Why are Americans paying more for the same drug?”
WASHINGTON—U.S. Senator Mike Braun questioned Novo Nordisk CEO, Lars Fruergaard Jørgensen, at the Senate Health, Education, ...
1d
Ozempic maker to testify before Senate committee on weight loss drug prices
Novo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee on ...
Managed Healthcare Executive
4h
Takeaways from Senate Hearing on Semaglutide Pricing
Novo Nordisk said it’s open to discussions with PBMs based on their commitments that a lower semgalutide list price would not ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Helene now hurricane
Workers lose arbitration
Would-be assassin charged
Gets 2-yrs for role in fraud
Penn suspends law professor
Campaign office damaged
Sounds nuclear alarm
Woman dies in 'suicide pod’
Study: Myopia on the rise
To cut Atlanta service, jobs
Chemical leak in OH county
CA new gun control laws
Israel intercepts first missile
US to waive visas for Qatar
NYC schools boss retiring
New home sales fall
Briefed on Iranian threats
Calls strike against 'LoL’
New COVID, flu shots
Pac-12 sues Mountain West
First transparency report
School book bans surge
Dog food recalled
Texas AG appeal denied
Fat Bear Week coming up
Exec apologizes for outage
Shippers seek workarounds
China conducts ICBM test
Senate report details lapses
WA abortion pill stockpile
Feedback